

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of protein kinase C signaling (GO:0090037) | 7.74771029 |
| 2 | endocrine pancreas development (GO:0031018) | 7.37227301 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.86124114 |
| 4 | peptide hormone processing (GO:0016486) | 6.40951480 |
| 5 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 6.29320928 |
| 6 | protein retention in ER lumen (GO:0006621) | 6.25142119 |
| 7 | COPII vesicle coating (GO:0048208) | 6.22754139 |
| 8 | protein maturation by protein folding (GO:0022417) | 6.00963898 |
| 9 | glandular epithelial cell differentiation (GO:0002067) | 5.44435657 |
| 10 | exocrine pancreas development (GO:0031017) | 5.32102188 |
| 11 | positive regulation of insulin secretion (GO:0032024) | 5.30788728 |
| 12 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.26316329 |
| 13 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.18247123 |
| 14 | signal peptide processing (GO:0006465) | 5.00471399 |
| 15 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 4.97063369 |
| 16 | type B pancreatic cell development (GO:0003323) | 4.93690009 |
| 17 | cellular response to vitamin D (GO:0071305) | 4.91068013 |
| 18 | insulin secretion (GO:0030073) | 4.90132191 |
| 19 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.88646466 |
| 20 | glandular epithelial cell development (GO:0002068) | 4.74269648 |
| 21 | sequestering of metal ion (GO:0051238) | 4.73956299 |
| 22 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.63769763 |
| 23 | positive regulation of nuclease activity (GO:0032075) | 4.63347516 |
| 24 | vesicle coating (GO:0006901) | 4.61085329 |
| 25 | regulation of insulin secretion (GO:0050796) | 4.39502927 |
| 26 | toxin metabolic process (GO:0009404) | 4.36000763 |
| 27 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 4.35459824 |
| 28 | positive regulation of peptide hormone secretion (GO:0090277) | 4.29215680 |
| 29 | regulation of nuclease activity (GO:0032069) | 4.21053445 |
| 30 | tricarboxylic acid metabolic process (GO:0072350) | 4.15494929 |
| 31 | negative regulation of cell size (GO:0045792) | 4.13914435 |
| 32 | positive regulation of peptide secretion (GO:0002793) | 4.12959743 |
| 33 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.05663365 |
| 34 | regulation of peptide hormone secretion (GO:0090276) | 4.00281072 |
| 35 | cellular response to unfolded protein (GO:0034620) | 3.97379876 |
| 36 | nitric oxide mediated signal transduction (GO:0007263) | 3.95111140 |
| 37 | regulation of protein kinase C signaling (GO:0090036) | 3.92588134 |
| 38 | regulation of peptide secretion (GO:0002791) | 3.92234397 |
| 39 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.91987521 |
| 40 | cellular response to topologically incorrect protein (GO:0035967) | 3.90748697 |
| 41 | semaphorin-plexin signaling pathway (GO:0071526) | 3.90286631 |
| 42 | drug transmembrane transport (GO:0006855) | 3.88019788 |
| 43 | peptide hormone secretion (GO:0030072) | 3.87980578 |
| 44 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.84342849 |
| 45 | regulation of ARF GTPase activity (GO:0032312) | 3.82804170 |
| 46 | epoxygenase P450 pathway (GO:0019373) | 3.79846545 |
| 47 | peptide secretion (GO:0002790) | 3.79728853 |
| 48 | ER-nucleus signaling pathway (GO:0006984) | 3.79431597 |
| 49 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.75169801 |
| 50 | endothelial cell morphogenesis (GO:0001886) | 3.72016033 |
| 51 | desmosome organization (GO:0002934) | 3.66070760 |
| 52 | macroautophagy (GO:0016236) | 3.61588722 |
| 53 | regulation of plasminogen activation (GO:0010755) | 3.61458963 |
| 54 | epithelial cell fate commitment (GO:0072148) | 3.60419992 |
| 55 | negative regulation of insulin secretion (GO:0046676) | 3.53906456 |
| 56 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.53080722 |
| 57 | positive regulation of glycolytic process (GO:0045821) | 3.52755859 |
| 58 | cellular response to vitamin (GO:0071295) | 3.51918773 |
| 59 | white fat cell differentiation (GO:0050872) | 3.49526170 |
| 60 | quaternary ammonium group transport (GO:0015697) | 3.48541603 |
| 61 | renal absorption (GO:0070293) | 3.43706164 |
| 62 | regulation of hormone secretion (GO:0046883) | 3.43287980 |
| 63 | ER overload response (GO:0006983) | 3.42698120 |
| 64 | mannose metabolic process (GO:0006013) | 3.42590878 |
| 65 | urogenital system development (GO:0001655) | 3.36573631 |
| 66 | cellular zinc ion homeostasis (GO:0006882) | 3.36170255 |
| 67 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.35917184 |
| 68 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.34603105 |
| 69 | peptidyl-asparagine modification (GO:0018196) | 3.34239186 |
| 70 | response to endoplasmic reticulum stress (GO:0034976) | 3.33539877 |
| 71 | astrocyte differentiation (GO:0048708) | 3.32692384 |
| 72 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.31804708 |
| 73 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.31628957 |
| 74 | response to hepatocyte growth factor (GO:0035728) | 3.31628957 |
| 75 | positive regulation of hormone secretion (GO:0046887) | 3.30890985 |
| 76 | response to hexose (GO:0009746) | 3.29304756 |
| 77 | phosphate ion transport (GO:0006817) | 3.27195479 |
| 78 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.26300780 |
| 79 | protein autoprocessing (GO:0016540) | 3.25500144 |
| 80 | response to glucose (GO:0009749) | 3.25156565 |
| 81 | metanephric nephron epithelium development (GO:0072243) | 3.21505699 |
| 82 | regulation of peptide transport (GO:0090087) | 3.21451713 |
| 83 | endothelial cell chemotaxis (GO:0035767) | 3.21280250 |
| 84 | 4-hydroxyproline metabolic process (GO:0019471) | 3.20979264 |
| 85 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.20859230 |
| 86 | detection of calcium ion (GO:0005513) | 3.20825135 |
| 87 | peptide transport (GO:0015833) | 3.18968993 |
| 88 | positive regulation of histone deacetylation (GO:0031065) | 3.18073130 |
| 89 | negative regulation of catecholamine secretion (GO:0033604) | 3.17082813 |
| 90 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.15438156 |
| 91 | negative regulation of norepinephrine secretion (GO:0010700) | 3.13979821 |
| 92 | drug transport (GO:0015893) | 3.13962633 |
| 93 | cell-cell junction maintenance (GO:0045217) | 3.13660484 |
| 94 | response to mercury ion (GO:0046689) | 3.13154780 |
| 95 | response to monosaccharide (GO:0034284) | 3.12646228 |
| 96 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.10387632 |
| 97 | phosphate ion transmembrane transport (GO:0035435) | 3.08649377 |
| 98 | hormone secretion (GO:0046879) | 3.08475261 |
| 99 | protein N-linked glycosylation (GO:0006487) | 3.07989385 |
| 100 | response to unfolded protein (GO:0006986) | 3.07931969 |
| 101 | growth hormone secretion (GO:0030252) | 3.07348949 |
| 102 | negative regulation of peptide hormone secretion (GO:0090278) | 3.06660928 |
| 103 | peptide metabolic process (GO:0006518) | 3.05626228 |
| 104 | peptide catabolic process (GO:0043171) | 3.05400026 |
| 105 | cell volume homeostasis (GO:0006884) | 3.05126454 |
| 106 | regulation of cholesterol metabolic process (GO:0090181) | 3.04558338 |
| 107 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.04420561 |
| 108 | protein carboxylation (GO:0018214) | 3.04420561 |
| 109 | Golgi organization (GO:0007030) | 3.04225298 |
| 110 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.04071903 |
| 111 | glucose homeostasis (GO:0042593) | 3.04042340 |
| 112 | carbohydrate homeostasis (GO:0033500) | 3.04042340 |
| 113 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.03882713 |
| 114 | response to topologically incorrect protein (GO:0035966) | 3.03104340 |
| 115 | actin filament depolymerization (GO:0030042) | 3.02234080 |
| 116 | drug catabolic process (GO:0042737) | 3.01360558 |
| 117 | toxin transport (GO:1901998) | 3.00564571 |
| 118 | metanephric nephron tubule development (GO:0072234) | 2.99721465 |
| 119 | metanephric tubule development (GO:0072170) | 2.99721465 |
| 120 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.98982486 |
| 121 | L-phenylalanine catabolic process (GO:0006559) | 2.98982486 |
| 122 | neuron remodeling (GO:0016322) | 2.98451862 |
| 123 | intestinal absorption (GO:0050892) | 2.98102255 |
| 124 | hormone transport (GO:0009914) | 2.97948681 |
| 125 | ear development (GO:0043583) | 2.97288953 |
| 126 | lung epithelium development (GO:0060428) | 2.95274714 |
| 127 | negative regulation of peptide secretion (GO:0002792) | 2.95109648 |
| 128 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.94550805 |
| 129 | urate metabolic process (GO:0046415) | 2.94217374 |
| 130 | cellular response to glucagon stimulus (GO:0071377) | 2.93743204 |
| 131 | trivalent inorganic anion homeostasis (GO:0072506) | 2.92629500 |
| 132 | phosphate ion homeostasis (GO:0055062) | 2.92629500 |
| 133 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.91304094 |
| 134 | nephron epithelium morphogenesis (GO:0072088) | 2.91275792 |
| 135 | nephron tubule morphogenesis (GO:0072078) | 2.91275792 |
| 136 | intestinal cholesterol absorption (GO:0030299) | 2.90073832 |
| 137 | atrioventricular valve morphogenesis (GO:0003181) | 2.88866776 |
| 138 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.88211932 |
| 139 | metanephric epithelium development (GO:0072207) | 2.88085761 |
| 140 | cellular response to nutrient (GO:0031670) | 2.87831611 |
| 141 | membrane repolarization during action potential (GO:0086011) | 2.87729717 |
| 142 | protein localization to Golgi apparatus (GO:0034067) | 2.87608206 |
| 143 | organic cation transport (GO:0015695) | 2.87474650 |
| 144 | regulation of protein activation cascade (GO:2000257) | 2.85691778 |
| 145 | positive regulation of hormone metabolic process (GO:0032352) | 2.85490850 |
| 146 | regulation of complement activation (GO:0030449) | 2.82275392 |
| 147 | high-density lipoprotein particle remodeling (GO:0034375) | 2.82220765 |
| 148 | regulation of apoptotic cell clearance (GO:2000425) | 2.82150073 |
| 149 | urea metabolic process (GO:0019627) | 2.78574457 |
| 150 | L-phenylalanine metabolic process (GO:0006558) | 2.77022733 |
| 151 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.77022733 |
| 152 | regulation of ruffle assembly (GO:1900027) | 2.73848553 |
| 153 | phospholipid efflux (GO:0033700) | 2.71754042 |
| 154 | regulation of triglyceride catabolic process (GO:0010896) | 2.71584723 |
| 155 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.70656886 |
| 156 | urea cycle (GO:0000050) | 2.70457530 |
| 157 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.70300230 |
| 158 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.70257103 |
| 159 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.70257103 |
| 160 | histone H3-K9 demethylation (GO:0033169) | 2.70101124 |
| 161 | phenylpropanoid metabolic process (GO:0009698) | 2.69658468 |
| 162 | chondroitin sulfate catabolic process (GO:0030207) | 2.64319386 |
| 163 | gonadal mesoderm development (GO:0007506) | 2.62673614 |
| 164 | drug metabolic process (GO:0017144) | 2.62011875 |
| 165 | regulation of fibrinolysis (GO:0051917) | 2.61510917 |
| 166 | cell junction maintenance (GO:0034331) | 2.61292698 |
| 167 | nephron tubule development (GO:0072080) | 2.61219587 |
| 168 | negative regulation of digestive system process (GO:0060457) | 2.59320928 |
| 169 | ethanol oxidation (GO:0006069) | 2.58874603 |
| 170 | regulation of extracellular matrix disassembly (GO:0010715) | 2.58594971 |
| 171 | sulfur amino acid catabolic process (GO:0000098) | 2.54521883 |
| 172 | negative regulation of catenin import into nucleus (GO:0035414) | 2.51292167 |
| 173 | complement activation, alternative pathway (GO:0006957) | 2.50620759 |
| 174 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.50583048 |
| 175 | lymph vessel development (GO:0001945) | 2.49915851 |
| 176 | reverse cholesterol transport (GO:0043691) | 2.48711537 |
| 177 | histone H4 deacetylation (GO:0070933) | 2.47914624 |
| 178 | epithelial cell-cell adhesion (GO:0090136) | 2.47675711 |
| 179 | collecting duct development (GO:0072044) | 2.47164551 |
| 180 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.47022429 |
| 181 | protein-lipid complex remodeling (GO:0034368) | 2.46504476 |
| 182 | macromolecular complex remodeling (GO:0034367) | 2.46504476 |
| 183 | plasma lipoprotein particle remodeling (GO:0034369) | 2.46504476 |
| 184 | regulation of synapse maturation (GO:0090128) | 2.46169917 |
| 185 | Golgi transport vesicle coating (GO:0048200) | 10.3200346 |
| 186 | COPI coating of Golgi vesicle (GO:0048205) | 10.3200346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 4.15998956 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 4.00925827 |
| 3 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.78688011 |
| 4 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.65589928 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.37245286 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.81299436 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.61048852 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.59597184 |
| 9 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.55132616 |
| 10 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.41118035 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.33743478 |
| 12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.32908223 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.29039961 |
| 14 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.26004820 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11418939 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.07200064 |
| 17 | P68_20966046_ChIP-Seq_HELA_Human | 2.05366994 |
| 18 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.02310024 |
| 19 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 2.01251777 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 10.0221813 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95588086 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94591876 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.94475250 |
| 24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.93326327 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.87196257 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.82057131 |
| 27 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.81546075 |
| 28 | KDM2B_26808549_Chip-Seq_K562_Human | 1.79536598 |
| 29 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.76322700 |
| 30 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.74763867 |
| 31 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.69464766 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.66318999 |
| 33 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.66301432 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64281445 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62777344 |
| 36 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.61797314 |
| 37 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.61557686 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59267802 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.58308720 |
| 40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.56425875 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55545074 |
| 42 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.51821545 |
| 43 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.51559430 |
| 44 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.50479936 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.49171390 |
| 46 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.48015197 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.47046678 |
| 48 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.46793445 |
| 49 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.43237247 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42393836 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40498612 |
| 52 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.39113804 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37513526 |
| 54 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.36656036 |
| 55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.35631913 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35560442 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34977371 |
| 58 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.30522376 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30505038 |
| 60 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.29625371 |
| 61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29378579 |
| 62 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28924286 |
| 63 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.28472335 |
| 64 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.27645057 |
| 65 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.27468359 |
| 66 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27227006 |
| 67 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26298923 |
| 68 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.25784487 |
| 69 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24921803 |
| 70 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24513081 |
| 71 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.24342375 |
| 72 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22767849 |
| 73 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.21496913 |
| 74 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.20470760 |
| 75 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.19878879 |
| 76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.19446552 |
| 77 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.19009070 |
| 78 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18663914 |
| 79 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18328152 |
| 80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.17376692 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17355594 |
| 82 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16449039 |
| 83 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15753794 |
| 84 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.14420645 |
| 85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14235776 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13436793 |
| 87 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12061472 |
| 88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11339460 |
| 89 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11206199 |
| 90 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.10097773 |
| 91 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09601605 |
| 92 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08885220 |
| 93 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.07717482 |
| 94 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.07373387 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07074427 |
| 96 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.07005299 |
| 97 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.06444449 |
| 98 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.06328561 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06303816 |
| 100 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.05853510 |
| 101 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05571369 |
| 102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05556528 |
| 103 | SA1_27219007_Chip-Seq_Bcells_Human | 1.05069035 |
| 104 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.04549809 |
| 105 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.04129153 |
| 106 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03331641 |
| 107 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02777634 |
| 108 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02776610 |
| 109 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01090084 |
| 110 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00834525 |
| 111 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00441408 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99997459 |
| 113 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.99961857 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99793218 |
| 115 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99366164 |
| 116 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.96822175 |
| 117 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.96402710 |
| 118 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.96268641 |
| 119 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96079724 |
| 120 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.95983042 |
| 121 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.95795442 |
| 122 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.95685798 |
| 123 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.95103246 |
| 124 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.94791690 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.94100369 |
| 126 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.92659508 |
| 127 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92625519 |
| 128 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92523593 |
| 129 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92483839 |
| 130 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92456318 |
| 131 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92373644 |
| 132 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.91153237 |
| 133 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90753701 |
| 134 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90083755 |
| 135 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.90048780 |
| 136 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.89772655 |
| 137 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89410769 |
| 138 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89318877 |
| 139 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.88529856 |
| 140 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88330010 |
| 141 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.88267323 |
| 142 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.87334489 |
| 143 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.86846950 |
| 144 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.85696980 |
| 145 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83246303 |
| 146 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83246303 |
| 147 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.81501869 |
| 148 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.81028195 |
| 149 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80793869 |
| 150 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80186685 |
| 151 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.80063809 |
| 152 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79580495 |
| 153 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78988864 |
| 154 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.77987479 |
| 155 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.77131961 |
| 156 | AR_20517297_ChIP-Seq_VCAP_Human | 0.77055688 |
| 157 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.77017060 |
| 158 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.76671576 |
| 159 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.75338051 |
| 160 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.75080636 |
| 161 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.73871660 |
| 162 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.73621413 |
| 163 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.73063586 |
| 164 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.72490206 |
| 165 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.72084157 |
| 166 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71809208 |
| 167 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.71288116 |
| 168 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.70874101 |
| 169 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.70104934 |
| 170 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.69981343 |
| 171 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.69465118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 5.11875985 |
| 2 | MP0003283_abnormal_digestive_organ | 4.81840003 |
| 3 | MP0003195_calcinosis | 4.65143654 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 4.44000714 |
| 5 | MP0005409_darkened_coat_color | 4.16650486 |
| 6 | MP0000013_abnormal_adipose_tissue | 4.05905993 |
| 7 | MP0002693_abnormal_pancreas_physiology | 3.79981222 |
| 8 | MP0001944_abnormal_pancreas_morphology | 3.66703622 |
| 9 | MP0002909_abnormal_adrenal_gland | 3.45200196 |
| 10 | MP0003183_abnormal_peptide_metabolism | 3.33988704 |
| 11 | MP0009780_abnormal_chondrocyte_physiolo | 3.33571987 |
| 12 | MP0003136_yellow_coat_color | 3.31678549 |
| 13 | MP0005220_abnormal_exocrine_pancreas | 3.19322083 |
| 14 | MP0005379_endocrine/exocrine_gland_phen | 3.10242916 |
| 15 | MP0000678_abnormal_parathyroid_gland | 3.06281955 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.96239191 |
| 17 | MP0010386_abnormal_urinary_bladder | 2.84940412 |
| 18 | MP0001188_hyperpigmentation | 2.61700945 |
| 19 | MP0002249_abnormal_larynx_morphology | 2.59811767 |
| 20 | MP0004381_abnormal_hair_follicle | 2.53772813 |
| 21 | MP0001765_abnormal_ion_homeostasis | 2.40506866 |
| 22 | MP0002928_abnormal_bile_duct | 2.29543889 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 2.28271814 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 2.24464420 |
| 25 | MP0002078_abnormal_glucose_homeostasis | 2.24275040 |
| 26 | MP0009643_abnormal_urine_homeostasis | 2.21232663 |
| 27 | MP0000003_abnormal_adipose_tissue | 2.17370572 |
| 28 | MP0010368_abnormal_lymphatic_system | 2.12365828 |
| 29 | MP0002139_abnormal_hepatobiliary_system | 2.11593767 |
| 30 | MP0000566_synostosis | 2.06869086 |
| 31 | MP0003300_gastrointestinal_ulcer | 2.03634961 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 2.00049073 |
| 33 | MP0001756_abnormal_urination | 1.97716560 |
| 34 | MP0006292_abnormal_olfactory_placode | 1.89948760 |
| 35 | MP0003252_abnormal_bile_duct | 1.89168351 |
| 36 | MP0005365_abnormal_bile_salt | 1.87814079 |
| 37 | MP0001849_ear_inflammation | 1.86341459 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.80764580 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 1.73099176 |
| 40 | MP0003122_maternal_imprinting | 1.70959259 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.70738936 |
| 42 | MP0010329_abnormal_lipoprotein_level | 1.66642124 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.63140137 |
| 44 | MP0009384_cardiac_valve_regurgitation | 1.60619617 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.59806211 |
| 46 | MP0000467_abnormal_esophagus_morphology | 1.58568496 |
| 47 | MP0002896_abnormal_bone_mineralization | 1.57102124 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.55836170 |
| 49 | MP0002822_catalepsy | 1.55097294 |
| 50 | MP0000462_abnormal_digestive_system | 1.53930907 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.47725562 |
| 52 | MP0004019_abnormal_vitamin_homeostasis | 1.44310504 |
| 53 | MP0005332_abnormal_amino_acid | 1.40418435 |
| 54 | MP0002234_abnormal_pharynx_morphology | 1.38590068 |
| 55 | MP0003953_abnormal_hormone_level | 1.38157426 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.37610156 |
| 57 | MP0003959_abnormal_lean_body | 1.37336264 |
| 58 | MP0005503_abnormal_tendon_morphology | 1.36873173 |
| 59 | MP0005360_urolithiasis | 1.31939481 |
| 60 | MP0001986_abnormal_taste_sensitivity | 1.28264488 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.27756751 |
| 62 | MP0000613_abnormal_salivary_gland | 1.20116389 |
| 63 | MP0001666_abnormal_nutrient_absorption | 1.19225181 |
| 64 | MP0003868_abnormal_feces_composition | 1.18670248 |
| 65 | MP0002933_joint_inflammation | 1.17462990 |
| 66 | MP0002163_abnormal_gland_morphology | 1.15466456 |
| 67 | MP0009840_abnormal_foam_cell | 1.12278314 |
| 68 | MP0002796_impaired_skin_barrier | 1.10284852 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.10172245 |
| 70 | MP0006054_spinal_hemorrhage | 1.10164144 |
| 71 | MP0005375_adipose_tissue_phenotype | 1.08908173 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.08776275 |
| 73 | MP0000538_abnormal_urinary_bladder | 1.07366691 |
| 74 | MP0005257_abnormal_intraocular_pressure | 1.06323831 |
| 75 | MP0005535_abnormal_body_temperature | 1.05923618 |
| 76 | MP0001270_distended_abdomen | 1.03956488 |
| 77 | MP0003279_aneurysm | 0.99618693 |
| 78 | MP0003878_abnormal_ear_physiology | 0.98589101 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 0.98589101 |
| 80 | MP0000230_abnormal_systemic_arterial | 0.97943014 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.96262697 |
| 82 | MP0004270_analgesia | 0.94965285 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.93313571 |
| 84 | MP0000371_diluted_coat_color | 0.93102241 |
| 85 | MP0003119_abnormal_digestive_system | 0.93075007 |
| 86 | MP0002282_abnormal_trachea_morphology | 0.89339140 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.89304168 |
| 88 | MP0005670_abnormal_white_adipose | 0.88858531 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 0.87881190 |
| 90 | MP0003938_abnormal_ear_development | 0.87656774 |
| 91 | MP0001764_abnormal_homeostasis | 0.87569388 |
| 92 | MP0008260_abnormal_autophagy | 0.86723253 |
| 93 | MP0000383_abnormal_hair_follicle | 0.86684321 |
| 94 | MP0005174_abnormal_tail_pigmentation | 0.86077282 |
| 95 | MP0005595_abnormal_vascular_smooth | 0.85147019 |
| 96 | MP0002132_abnormal_respiratory_system | 0.84937486 |
| 97 | MP0004272_abnormal_basement_membrane | 0.84535520 |
| 98 | MP0001958_emphysema | 0.82892785 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.82332479 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.82086784 |
| 101 | MP0001348_abnormal_lacrimal_gland | 0.81298523 |
| 102 | MP0002168_other_aberrant_phenotype | 0.80813657 |
| 103 | MP0005310_abnormal_salivary_gland | 0.80619171 |
| 104 | MP0002932_abnormal_joint_morphology | 0.80571535 |
| 105 | MP0003045_fibrosis | 0.79870127 |
| 106 | MP0010678_abnormal_skin_adnexa | 0.78509711 |
| 107 | MP0003115_abnormal_respiratory_system | 0.74823934 |
| 108 | MP0005408_hypopigmentation | 0.74817708 |
| 109 | MP0002118_abnormal_lipid_homeostasis | 0.74111576 |
| 110 | MP0005085_abnormal_gallbladder_physiolo | 0.73190949 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.72917738 |
| 112 | MP0003866_abnormal_defecation | 0.71719713 |
| 113 | MP0001661_extended_life_span | 0.71543525 |
| 114 | MP0005448_abnormal_energy_balance | 0.71351381 |
| 115 | MP0002254_reproductive_system_inflammat | 0.71135148 |
| 116 | MP0002108_abnormal_muscle_morphology | 0.69958545 |
| 117 | MP0010234_abnormal_vibrissa_follicle | 0.69631680 |
| 118 | MP0008872_abnormal_physiological_respon | 0.69442137 |
| 119 | MP0003942_abnormal_urinary_system | 0.68558859 |
| 120 | MP0009672_abnormal_birth_weight | 0.68414873 |
| 121 | MP0009642_abnormal_blood_homeostasis | 0.68326089 |
| 122 | MP0004133_heterotaxia | 0.68056041 |
| 123 | MP0005083_abnormal_biliary_tract | 0.65123135 |
| 124 | MP0000751_myopathy | 0.64730175 |
| 125 | MP0003787_abnormal_imprinting | 0.64442197 |
| 126 | MP0003123_paternal_imprinting | 0.64397491 |
| 127 | MP0006138_congestive_heart_failure | 0.64346089 |
| 128 | MP0000639_abnormal_adrenal_gland | 0.63407095 |
| 129 | MP0003879_abnormal_hair_cell | 0.62765121 |
| 130 | MP0001299_abnormal_eye_distance/ | 0.58270118 |
| 131 | MP0002938_white_spotting | 0.57105896 |
| 132 | MP0001664_abnormal_digestion | 0.57028280 |
| 133 | MP0001502_abnormal_circadian_rhythm | 0.55970833 |
| 134 | MP0006036_abnormal_mitochondrial_physio | 0.54668644 |
| 135 | MP0002069_abnormal_eating/drinking_beha | 0.54426264 |
| 136 | MP0003795_abnormal_bone_structure | 0.52463384 |
| 137 | MP0009703_decreased_birth_body | 0.51777590 |
| 138 | MP0005187_abnormal_penis_morphology | 0.48317868 |
| 139 | MP0000163_abnormal_cartilage_morphology | 0.48064900 |
| 140 | MP0005452_abnormal_adipose_tissue | 0.47234678 |
| 141 | MP0000609_abnormal_liver_physiology | 0.46980924 |
| 142 | MP0004885_abnormal_endolymph | 0.46704087 |
| 143 | MP0005253_abnormal_eye_physiology | 0.46396967 |
| 144 | MP0003890_abnormal_embryonic-extraembry | 0.45757067 |
| 145 | MP0008875_abnormal_xenobiotic_pharmacok | 0.45543069 |
| 146 | MP0001731_abnormal_postnatal_growth | 0.45086724 |
| 147 | MP0003943_abnormal_hepatobiliary_system | 0.44087446 |
| 148 | MP0000681_abnormal_thyroid_gland | 0.43284800 |
| 149 | MP0004233_abnormal_muscle_weight | 0.42995096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.59335970 |
| 2 | Hypoglycemic seizures (HP:0002173) | 7.07807434 |
| 3 | Hypoglycemic coma (HP:0001325) | 6.59920817 |
| 4 | Symptomatic seizures (HP:0011145) | 6.50294890 |
| 5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.42083637 |
| 6 | J-shaped sella turcica (HP:0002680) | 6.12087786 |
| 7 | Lymphangioma (HP:0100764) | 5.45441909 |
| 8 | Ketoacidosis (HP:0001993) | 5.35731745 |
| 9 | Late onset (HP:0003584) | 4.75787384 |
| 10 | Hyperglycemia (HP:0003074) | 4.74404333 |
| 11 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.61613041 |
| 12 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.61613041 |
| 13 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.61188638 |
| 14 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.59202138 |
| 15 | Gout (HP:0001997) | 4.58334472 |
| 16 | Nuclear cataract (HP:0100018) | 4.41223122 |
| 17 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.32013380 |
| 18 | Increased circulating renin level (HP:0000848) | 4.31693112 |
| 19 | Hyperactive renin-angiotensin system (HP:0000841) | 4.04028270 |
| 20 | Generalized aminoaciduria (HP:0002909) | 4.02509166 |
| 21 | Large for gestational age (HP:0001520) | 4.01826329 |
| 22 | Hypokalemia (HP:0002900) | 4.00443526 |
| 23 | Abnormal pancreas size (HP:0012094) | 3.96670819 |
| 24 | Abnormality of renin-angiotensin system (HP:0000847) | 3.74540665 |
| 25 | Hypokalemic alkalosis (HP:0001949) | 3.72226595 |
| 26 | Decreased circulating renin level (HP:0003351) | 3.63063345 |
| 27 | Cervical subluxation (HP:0003308) | 3.62720974 |
| 28 | Abnormality of chloride homeostasis (HP:0011422) | 3.61752849 |
| 29 | Obstructive sleep apnea (HP:0002870) | 3.56857894 |
| 30 | Visceral angiomatosis (HP:0100761) | 3.54911463 |
| 31 | Broad face (HP:0000283) | 3.44239415 |
| 32 | Ketosis (HP:0001946) | 3.40491104 |
| 33 | Dysostosis multiplex (HP:0000943) | 3.29214913 |
| 34 | Deformed sella turcica (HP:0002681) | 3.26968635 |
| 35 | Polyuria (HP:0000103) | 3.26308364 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.26183703 |
| 37 | Mucopolysacchariduria (HP:0008155) | 3.26183703 |
| 38 | Abnormality of potassium homeostasis (HP:0011042) | 3.23614803 |
| 39 | Hypomagnesemia (HP:0002917) | 3.23274096 |
| 40 | Hemangiomatosis (HP:0007461) | 3.22627186 |
| 41 | Neoplasm of the heart (HP:0100544) | 3.11541346 |
| 42 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.09729938 |
| 43 | Deep venous thrombosis (HP:0002625) | 3.07881515 |
| 44 | Metabolic alkalosis (HP:0200114) | 3.07578395 |
| 45 | Broad metatarsal (HP:0001783) | 3.06963350 |
| 46 | Abnormal urine output (HP:0012590) | 3.02786465 |
| 47 | Insulin resistance (HP:0000855) | 3.02033162 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.00227244 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.00227244 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.00227244 |
| 51 | Esophageal varix (HP:0002040) | 2.97858604 |
| 52 | Hyperparathyroidism (HP:0000843) | 2.96594650 |
| 53 | Abnormal drinking behavior (HP:0030082) | 2.93404273 |
| 54 | Polydipsia (HP:0001959) | 2.93404273 |
| 55 | Abnormality of magnesium homeostasis (HP:0004921) | 2.93349579 |
| 56 | Vitreoretinal degeneration (HP:0000655) | 2.91643849 |
| 57 | Osteomalacia (HP:0002749) | 2.83223955 |
| 58 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.81487211 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.79426395 |
| 60 | Abnormality of renal excretion (HP:0011036) | 2.76665331 |
| 61 | Tetany (HP:0001281) | 2.74859926 |
| 62 | Unilateral renal agenesis (HP:0000122) | 2.73551302 |
| 63 | Hyperaldosteronism (HP:0000859) | 2.70515553 |
| 64 | Retinal atrophy (HP:0001105) | 2.69979447 |
| 65 | Wrist flexion contracture (HP:0001239) | 2.69767674 |
| 66 | Complement deficiency (HP:0004431) | 2.69712410 |
| 67 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.69693744 |
| 68 | Joint stiffness (HP:0001387) | 2.69086394 |
| 69 | Severe Myopia (HP:0011003) | 2.68408742 |
| 70 | Hemorrhage of the eye (HP:0011885) | 2.68360494 |
| 71 | Hyperphosphaturia (HP:0003109) | 2.65240102 |
| 72 | Hypophosphatemia (HP:0002148) | 2.63953986 |
| 73 | Stridor (HP:0010307) | 2.57221068 |
| 74 | Ependymoma (HP:0002888) | 2.56643062 |
| 75 | Glycosuria (HP:0003076) | 2.55785367 |
| 76 | Abnormality of urine glucose concentration (HP:0011016) | 2.55785367 |
| 77 | Malnutrition (HP:0004395) | 2.54983401 |
| 78 | Potter facies (HP:0002009) | 2.52240773 |
| 79 | Facial shape deformation (HP:0011334) | 2.52240773 |
| 80 | Hyperuricemia (HP:0002149) | 2.49395561 |
| 81 | Increased purine levels (HP:0004368) | 2.49395561 |
| 82 | Agitation (HP:0000713) | 2.47210417 |
| 83 | Alkalosis (HP:0001948) | 2.46934616 |
| 84 | Proximal tubulopathy (HP:0000114) | 2.44464563 |
| 85 | Focal segmental glomerulosclerosis (HP:0000097) | 2.42806780 |
| 86 | Conjugated hyperbilirubinemia (HP:0002908) | 2.42034189 |
| 87 | Prominent metopic ridge (HP:0005487) | 2.39626502 |
| 88 | Biconcave vertebral bodies (HP:0004586) | 2.39258569 |
| 89 | Xanthomatosis (HP:0000991) | 2.37087266 |
| 90 | Mitral stenosis (HP:0001718) | 2.36811281 |
| 91 | Delayed CNS myelination (HP:0002188) | 2.36538328 |
| 92 | Hypotension (HP:0002615) | 2.35623257 |
| 93 | Hyperkalemia (HP:0002153) | 2.35510849 |
| 94 | Cerebral aneurysm (HP:0004944) | 2.34116364 |
| 95 | Metaphyseal cupping (HP:0003021) | 2.33352871 |
| 96 | Exocrine pancreatic insufficiency (HP:0001738) | 2.32507877 |
| 97 | Hyperphosphatemia (HP:0002905) | 2.32442671 |
| 98 | Bronchomalacia (HP:0002780) | 2.31381363 |
| 99 | Adrenal overactivity (HP:0002717) | 2.29565278 |
| 100 | Glomerulonephritis (HP:0000099) | 2.28950299 |
| 101 | Nonimmune hydrops fetalis (HP:0001790) | 2.28032508 |
| 102 | Hypoplastic ischia (HP:0003175) | 2.27405689 |
| 103 | Round ear (HP:0100830) | 2.24982228 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 2.24691718 |
| 105 | Spinal canal stenosis (HP:0003416) | 2.23978292 |
| 106 | Abnormal urine phosphate concentration (HP:0012599) | 2.23736313 |
| 107 | Renal salt wasting (HP:0000127) | 2.23404781 |
| 108 | Abdominal distention (HP:0003270) | 2.22946914 |
| 109 | Neonatal death (HP:0003811) | 2.21719256 |
| 110 | Vacuolated lymphocytes (HP:0001922) | 2.21349000 |
| 111 | Limb hypertonia (HP:0002509) | 2.21107830 |
| 112 | Abnormality of the intrinsic pathway (HP:0010989) | 2.18667281 |
| 113 | Skin nodule (HP:0200036) | 2.15629917 |
| 114 | Flat acetabular roof (HP:0003180) | 2.15407563 |
| 115 | Dysautonomia (HP:0002459) | 2.10445835 |
| 116 | Cerebral palsy (HP:0100021) | 2.10404138 |
| 117 | Hyperlipoproteinemia (HP:0010980) | 2.09423641 |
| 118 | Easy fatigability (HP:0003388) | 2.08045605 |
| 119 | Pheochromocytoma (HP:0002666) | 2.07691743 |
| 120 | Abnormality of the sella turcica (HP:0002679) | 2.07362077 |
| 121 | Abnormality of complement system (HP:0005339) | 2.07247907 |
| 122 | Hypercalciuria (HP:0002150) | 2.04442606 |
| 123 | Protuberant abdomen (HP:0001538) | 2.03800436 |
| 124 | Shallow orbits (HP:0000586) | 2.01321374 |
| 125 | Joint hemorrhage (HP:0005261) | 2.00866670 |
| 126 | Glomerulosclerosis (HP:0000096) | 1.99689731 |
| 127 | Aortic valve stenosis (HP:0001650) | 1.99625947 |
| 128 | Abnormality of the metopic suture (HP:0005556) | 1.98866869 |
| 129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97488658 |
| 130 | Enlarged kidneys (HP:0000105) | 1.97108930 |
| 131 | Male infertility (HP:0003251) | 1.97041993 |
| 132 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.96167379 |
| 133 | Hypsarrhythmia (HP:0002521) | 1.95298543 |
| 134 | EEG with generalized epileptiform discharges (HP:0011198) | 1.94864477 |
| 135 | Pigmentary retinal degeneration (HP:0001146) | 1.94081436 |
| 136 | Prolonged partial thromboplastin time (HP:0003645) | 1.93550506 |
| 137 | Hepatoblastoma (HP:0002884) | 1.93156050 |
| 138 | Upper limb amyotrophy (HP:0009129) | 1.91665890 |
| 139 | Distal upper limb amyotrophy (HP:0007149) | 1.91665890 |
| 140 | Testicular atrophy (HP:0000029) | 1.91436983 |
| 141 | Hypoalphalipoproteinemia (HP:0003233) | 1.88978433 |
| 142 | Hypercortisolism (HP:0001578) | 1.88615004 |
| 143 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88533980 |
| 144 | Thoracolumbar scoliosis (HP:0002944) | 1.88267487 |
| 145 | Skull defect (HP:0001362) | 1.88006654 |
| 146 | Irritability (HP:0000737) | 1.84814513 |
| 147 | Abnormality of the ischium (HP:0003174) | 1.84702633 |
| 148 | Epileptiform EEG discharges (HP:0011182) | 1.84004290 |
| 149 | Progressive neurologic deterioration (HP:0002344) | 1.79769609 |
| 150 | Elevated alkaline phosphatase (HP:0003155) | 1.79694340 |
| 151 | Menstrual irregularities (HP:0000858) | 1.79046086 |
| 152 | Aortic regurgitation (HP:0001659) | 1.78317988 |
| 153 | Thin bony cortex (HP:0002753) | 1.77508614 |
| 154 | Abnormality of the femoral head (HP:0003368) | 1.77388818 |
| 155 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.77241324 |
| 156 | Metaphyseal irregularity (HP:0003025) | 1.77036133 |
| 157 | Hypobetalipoproteinemia (HP:0003563) | 1.76501019 |
| 158 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.76378212 |
| 159 | Atelectasis (HP:0100750) | 1.75715050 |
| 160 | Neuroendocrine neoplasm (HP:0100634) | 1.75468554 |
| 161 | Hydroxyprolinuria (HP:0003080) | 1.73685658 |
| 162 | Tachypnea (HP:0002789) | 1.73372112 |
| 163 | Nephrolithiasis (HP:0000787) | 1.71975836 |
| 164 | Disproportionate short-trunk short stature (HP:0003521) | 1.64109452 |
| 165 | Abnormality of nucleobase metabolism (HP:0010932) | 1.64033220 |
| 166 | Widely patent fontanelles and sutures (HP:0004492) | 1.63424722 |
| 167 | Delayed epiphyseal ossification (HP:0002663) | 1.63313037 |
| 168 | Congenital glaucoma (HP:0001087) | 1.63063934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 6.82892402 |
| 2 | MAPK15 | 6.58041166 |
| 3 | WNK3 | 5.22861382 |
| 4 | PASK | 4.78651413 |
| 5 | WNK4 | 4.52347864 |
| 6 | KDR | 3.46501898 |
| 7 | PRKD3 | 3.26366423 |
| 8 | TAOK3 | 2.87135335 |
| 9 | MAP2K6 | 2.77869761 |
| 10 | HIPK2 | 2.52163098 |
| 11 | TNK2 | 2.45380580 |
| 12 | FRK | 2.36929258 |
| 13 | MUSK | 2.25363671 |
| 14 | MAP3K2 | 2.17498766 |
| 15 | ERN1 | 2.16689112 |
| 16 | NME1 | 2.11730400 |
| 17 | FLT3 | 2.08365288 |
| 18 | MAP3K6 | 2.07217253 |
| 19 | PIK3CG | 2.06154203 |
| 20 | PKN2 | 1.86008623 |
| 21 | ERBB2 | 1.80220693 |
| 22 | MAP3K7 | 1.77332830 |
| 23 | FGFR2 | 1.73289513 |
| 24 | NTRK1 | 1.67364308 |
| 25 | UHMK1 | 1.48694446 |
| 26 | MAP3K1 | 1.47960893 |
| 27 | SCYL2 | 1.46579375 |
| 28 | PTK2 | 1.37276420 |
| 29 | PDGFRA | 1.35432883 |
| 30 | DYRK1B | 1.33556599 |
| 31 | PTK6 | 1.26646948 |
| 32 | BMX | 1.26021493 |
| 33 | EPHA3 | 1.23267832 |
| 34 | BCKDK | 1.23175866 |
| 35 | WNK1 | 1.19277229 |
| 36 | OXSR1 | 1.18956738 |
| 37 | MET | 1.14468166 |
| 38 | CAMKK2 | 1.12368128 |
| 39 | LMTK2 | 1.11415139 |
| 40 | PRKD2 | 1.10975566 |
| 41 | FGFR3 | 1.09994187 |
| 42 | TRIB3 | 1.08522125 |
| 43 | RPS6KL1 | 1.02387620 |
| 44 | RPS6KC1 | 1.02387620 |
| 45 | PRKCH | 1.02364488 |
| 46 | IRAK3 | 0.99829688 |
| 47 | PAK3 | 0.98142151 |
| 48 | CDC42BPA | 0.98106872 |
| 49 | DDR2 | 0.96676757 |
| 50 | FGFR4 | 0.94375533 |
| 51 | MAP2K2 | 0.93673571 |
| 52 | IRAK1 | 0.93224996 |
| 53 | BRSK2 | 0.89093873 |
| 54 | RPS6KA6 | 0.87324935 |
| 55 | PRKAA2 | 0.86907886 |
| 56 | DAPK2 | 0.83780341 |
| 57 | EPHA2 | 0.79598767 |
| 58 | FER | 0.75612387 |
| 59 | NTRK3 | 0.71242314 |
| 60 | SIK1 | 0.70867964 |
| 61 | SIK2 | 0.69887463 |
| 62 | TAOK1 | 0.68680415 |
| 63 | PAK4 | 0.68548186 |
| 64 | EIF2AK3 | 0.68393037 |
| 65 | MAP4K1 | 0.66763890 |
| 66 | TBK1 | 0.64561323 |
| 67 | ICK | 0.64214577 |
| 68 | PRKCI | 0.62559231 |
| 69 | FGFR1 | 0.61255553 |
| 70 | MAPKAPK3 | 0.60561751 |
| 71 | PTK2B | 0.58605325 |
| 72 | MAP3K11 | 0.57241998 |
| 73 | MAPK8 | 0.56522984 |
| 74 | EEF2K | 0.56489971 |
| 75 | STK38 | 0.55840347 |
| 76 | PDPK1 | 0.54336467 |
| 77 | RIPK1 | 0.52670279 |
| 78 | GRK6 | 0.52311054 |
| 79 | EPHB1 | 0.50457398 |
| 80 | ROCK1 | 0.49958533 |
| 81 | GSK3A | 0.48986407 |
| 82 | TIE1 | 0.48249149 |
| 83 | BRD4 | 0.47691655 |
| 84 | PRKAA1 | 0.47492886 |
| 85 | SMG1 | 0.47286826 |
| 86 | SGK223 | 0.46494901 |
| 87 | SGK494 | 0.46494901 |
| 88 | ITK | 0.46091434 |
| 89 | MAP3K3 | 0.45749222 |
| 90 | JAK2 | 0.43977317 |
| 91 | EPHB2 | 0.43589416 |
| 92 | PRKCE | 0.41735179 |
| 93 | MAPK7 | 0.40850130 |
| 94 | STK38L | 0.39644701 |
| 95 | PHKG2 | 0.39465780 |
| 96 | PHKG1 | 0.39465780 |
| 97 | CSK | 0.38995616 |
| 98 | SRC | 0.38235434 |
| 99 | MAP2K3 | 0.38118917 |
| 100 | MAPK1 | 0.37294721 |
| 101 | IRAK2 | 0.36839352 |
| 102 | SIK3 | 0.36677456 |
| 103 | TESK1 | 0.36629397 |
| 104 | MTOR | 0.36402211 |
| 105 | MAPK3 | 0.34291524 |
| 106 | CDK9 | 0.33686405 |
| 107 | CAMK2D | 0.33005313 |
| 108 | BRAF | 0.32491923 |
| 109 | STK39 | 0.31437092 |
| 110 | RET | 0.31119694 |
| 111 | PIK3CA | 0.30329826 |
| 112 | NLK | 0.30193148 |
| 113 | IKBKE | 0.29938955 |
| 114 | ZAP70 | 0.29935000 |
| 115 | MATK | 0.29724044 |
| 116 | RPS6KA1 | 0.29239156 |
| 117 | STK16 | 0.29008439 |
| 118 | TYRO3 | 0.27781579 |
| 119 | PRKACG | 0.27246741 |
| 120 | ACVR1B | 0.27120303 |
| 121 | PRKD1 | 0.26886666 |
| 122 | KSR2 | 0.26106139 |
| 123 | JAK3 | 0.25851457 |
| 124 | TYK2 | 0.25795054 |
| 125 | AKT3 | 0.24054183 |
| 126 | DYRK3 | 0.23873985 |
| 127 | CSNK1A1 | 0.23545432 |
| 128 | MARK2 | 0.23120989 |
| 129 | IGF1R | 0.22588749 |
| 130 | MAP2K1 | 0.21554322 |
| 131 | CHUK | 0.21376431 |
| 132 | PRKACA | 0.21006023 |
| 133 | BRSK1 | 0.20778740 |
| 134 | PRKG2 | 0.20504287 |
| 135 | BMPR1B | 0.19286886 |
| 136 | SGK3 | 0.19213601 |
| 137 | SGK2 | 0.18469981 |
| 138 | JAK1 | 0.17717191 |
| 139 | SGK1 | 0.17416768 |
| 140 | PDGFRB | 0.17031639 |
| 141 | PRKDC | 0.16898000 |
| 142 | BCR | 0.16167641 |
| 143 | CAMK2B | 0.15878638 |
| 144 | PRKCA | 0.15820284 |
| 145 | DYRK1A | 0.15076873 |
| 146 | RPS6KA2 | 0.13558434 |
| 147 | CAMKK1 | 0.13388403 |
| 148 | MAPK14 | 0.13255145 |
| 149 | CDK5 | 0.12601483 |
| 150 | LATS1 | 0.11930053 |
| 151 | MST1R | 0.10497654 |
| 152 | RPS6KA3 | 0.10086759 |
| 153 | BTK | 0.10027292 |
| 154 | NEK6 | 0.08806171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 9.60527113 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.63513742 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.57752545 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.30107899 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 3.00686743 |
| 6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.89234298 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.71881033 |
| 8 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.43988984 |
| 9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.15990664 |
| 10 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.09744225 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.02406129 |
| 12 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.99724852 |
| 13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.99435142 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.91227914 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.86642230 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.85108813 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.77950492 |
| 18 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74320775 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71360800 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58514101 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58484713 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.58141370 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.55723040 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.48207534 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.48039568 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.45745542 |
| 27 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.45050115 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.44300108 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.43499029 |
| 30 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.43118791 |
| 31 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.37864087 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35512448 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.34337335 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30478262 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.28927995 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26263459 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20020857 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.19891370 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19061273 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.15900699 |
| 41 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.10964750 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.10463153 |
| 43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.09436351 |
| 44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.01248600 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.99138700 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.98362804 |
| 47 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.97911670 |
| 48 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.97614991 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96045575 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.93492555 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90974928 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90821254 |
| 53 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.89142703 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88623463 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.87282852 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.86059740 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82906513 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82828026 |
| 59 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.81806292 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81721600 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80838876 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79133638 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78936899 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78716389 |
| 65 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.77868412 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74749931 |
| 67 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74374459 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73354116 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70718456 |
| 70 | Taste transduction_Homo sapiens_hsa04742 | 0.70398136 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69474012 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.66365539 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66345448 |
| 74 | Histidine metabolism_Homo sapiens_hsa00340 | 0.65501975 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.64176317 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63469341 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63281395 |
| 78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62845405 |
| 79 | Axon guidance_Homo sapiens_hsa04360 | 0.60740353 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60710413 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60451045 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57049905 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.56315254 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.56089732 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55973175 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55325289 |
| 87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.54593545 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54037594 |
| 89 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51611238 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50114702 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49553116 |
| 92 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.47324707 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.45943841 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45473826 |
| 95 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.44053735 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42290346 |
| 97 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42092795 |
| 98 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41687567 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41544407 |
| 100 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.40287776 |
| 101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.40057371 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.40007331 |
| 103 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39829108 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38909394 |
| 105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38098017 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37091184 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37043225 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34902325 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34673919 |
| 110 | GABAergic synapse_Homo sapiens_hsa04727 | 0.34218850 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.33349885 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32995688 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32726045 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31822015 |
| 115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31318807 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30424682 |
| 117 | Long-term potentiation_Homo sapiens_hsa04720 | 0.30043776 |
| 118 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.29256617 |
| 119 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28129700 |
| 120 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.27720884 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27585599 |
| 122 | Circadian entrainment_Homo sapiens_hsa04713 | 0.26090918 |
| 123 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.23986099 |
| 124 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.23597208 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.23361217 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.23130440 |
| 127 | Alcoholism_Homo sapiens_hsa05034 | 0.22657296 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20933746 |
| 129 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.20453947 |
| 130 | Thyroid cancer_Homo sapiens_hsa05216 | 0.19242291 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.17725817 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.16912163 |
| 133 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.16810412 |
| 134 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.16004863 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.15606115 |
| 136 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.15604996 |
| 137 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.15217515 |
| 138 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.14708484 |
| 139 | Renin secretion_Homo sapiens_hsa04924 | 0.14660616 |

